Concord Wealth Partners’s GSK GSK Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $29.3K | Buy |
|
|||||
|
2025
Q1 | $25.7K | Sell |
|
|||||
|
2024
Q4 | $24.9K | Sell |
|
|||||
|
2024
Q3 | $32K | Buy |
|
|||||
|
2024
Q2 | $9.09K | Sell |
|
|||||
|
2024
Q1 | $61.6K | Buy |
|
|||||
|
2023
Q4 | $31.4K | Sell |
|
|||||
|
2023
Q3 | $85K | Buy |
|
|||||
|
2023
Q2 | $42.9K | Buy |
|
|||||
|
2023
Q1 | $41.4K | Sell |
|
|||||
|
2022
Q4 | $45.4K | Buy |
|
|||||
|
2022
Q3 | – | Sell |
|
|||||
|
2022
Q2 | $69K | Sell |
|
|||||
|
2022
Q1 | $151K | Sell |
|
|||||
|
2021
Q4 | $155K | Buy |
|
|||||
|
2021
Q3 | $26K | Sell |
|
|||||
|
2021
Q2 | $109K | Buy |
|
|||||
|
2021
Q1 | $67K | Buy |
|
|||||
|
2020
Q4 | $29K | Buy |
|